Cite Filings / MBX / 0001193125-26-039475
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

MBX Biosciences, Inc. · Filed 2026-02-05 · Acc 0001193125-26-039475

Other events

  • Item 8.01 Other events

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , mbx-20260204.htm

Around this filing

  • 2026-02-27 8-K Material agreement · Executive or director change
  • 2026-02-10 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-02-05 8-K Other events
  • 2026-02-03 4 Chief Medical Officer acquired 15,000 shares (grant or award)
  • 2026-02-03 4 Chief Financial Officer acquired 15,000 shares (grant or award)
  • 2026-02-03 4 President & CEO acquired 35,250 shares (grant or award)
  • 2026-01-22 8-K Executive or director change · Regulation FD disclosure

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading mbx-20260204.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…